Hochschulschrift
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
322 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Enthält 5 Sonderabdrucke aus verschiedenen Zeitschriften
Medizinische Hochschule Hannover, Dissertation, 2020
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wann)
-
April 2020
- Urheber
- Beteiligte Personen und Organisationen
-
Heuser, Michael
Chaturvedi, Anuhar
Pich, Andreas
Menon, Manoj Balakrishna
Medizinische Hochschule Hannover
Hannover Biomedical Research School
Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:11 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Gupta, Charu
- Heuser, Michael
- Chaturvedi, Anuhar
- Pich, Andreas
- Menon, Manoj Balakrishna
- Medizinische Hochschule Hannover
- Hannover Biomedical Research School
- Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation
Entstanden
- April 2020
Ähnliche Objekte (12)
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Functional characterisation of mutant isocitrate dehydrogenase in acute myeloid leukemia
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Myelodysplastic syndromes and acute myeloid leukemia : a biological and therapeutic continuum
Genetic and nano-therapeutic interventions to understand and target myeloid leukemia
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia
New Therapeutic Approaches for Cell Growth Inhibition of Acute Myeloid & Lymphoblastic Leukemia
Therapeutic resistance in acute myeloid leukemia: the role of non-coding RNAs
Evaluation of BH3 mimetics as a novel therapeutic strategy in acute myeloid leukemia
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Genetic and therapeutic profiling of acute myeloid/T-lymphoid leukemia from T-cell progenitors
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Functional characterisation of mutant isocitrate dehydrogenase in acute myeloid leukemia
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Myelodysplastic syndromes and acute myeloid leukemia : a biological and therapeutic continuum
Genetic and nano-therapeutic interventions to understand and target myeloid leukemia
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia
New Therapeutic Approaches for Cell Growth Inhibition of Acute Myeloid & Lymphoblastic Leukemia
Therapeutic resistance in acute myeloid leukemia: the role of non-coding RNAs
Evaluation of BH3 mimetics as a novel therapeutic strategy in acute myeloid leukemia
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Genetic and therapeutic profiling of acute myeloid/T-lymphoid leukemia from T-cell progenitors
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Functional characterisation of mutant isocitrate dehydrogenase in acute myeloid leukemia
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Myelodysplastic syndromes and acute myeloid leukemia : a biological and therapeutic continuum
Genetic and nano-therapeutic interventions to understand and target myeloid leukemia
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia
New Therapeutic Approaches for Cell Growth Inhibition of Acute Myeloid & Lymphoblastic Leukemia
Therapeutic resistance in acute myeloid leukemia: the role of non-coding RNAs
Evaluation of BH3 mimetics as a novel therapeutic strategy in acute myeloid leukemia
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia